Sandoz-Ciba: Novartis or Just-Bigger-Artis?
The Sandoz-Ciba merger is getting lots of analyst praise, but it’s unclear how burdening Sandoz’s valuable product line with Ciba’s unproductive research will help matters.
You may also be interested in...
If President Donald Trump appoints, and the Senate approves, a new conservative justice for the Supreme Court to replace Ruth Bader Ginsburg, Affordable Care Act coverage could disappear. Two legal experts weigh in on this and other legal issues that could touch the medical device industry.
The Dutch start-up will use the funds to finalize product design for a neurostimulation platform targeting chronic migraines.
Signifier Medical Technologies is ramping up commercialization of its technology solutions for patients with snoring and sleep disordered breathing conditions.